These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30872706)

  • 1. Pathogenetic basis of Takenouchi-Kosaki syndrome: Electron microscopy study using platelets in patients and functional studies in a Caenorhabditis elegans model.
    Uehara T; Suzuki H; Okamoto N; Kondoh T; Ahmad A; O'Connor BC; Yoshina S; Mitani S; Kosaki K; Takenouchi T
    Sci Rep; 2019 Mar; 9(1):4418. PubMed ID: 30872706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hot-spot mutation in CDC42 (p.Tyr64Cys) and novel phenotypes in the third patient with Takenouchi-Kosaki syndrome.
    Motokawa M; Watanabe S; Nakatomi A; Kondoh T; Matsumoto T; Morifuji K; Sawada H; Nishimura T; Nunoi H; Yoshiura KI; Moriuchi H; Dateki S
    J Hum Genet; 2018 Mar; 63(3):387-390. PubMed ID: 29335451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical phenotype with gastrostomy and abdominal wall infection in a pediatric patient with Takenouchi-Kosaki syndrome due to a heterozygous c.191A > G (p.Tyr64Cys) variant in
    Szczawińska-Popłonyk A; Popłonyk N; Badura-Stronka M; Juengling J; Huhn K; Biskup S; Bancerz B; Walkowiak J
    Front Genet; 2023; 14():1108852. PubMed ID: 37347054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific- and lipidation inhibitors in MEG-01 cells.
    Daimon E; Shibukawa Y; Thanasegaran S; Yamazaki N; Okamoto N
    Sci Rep; 2021 Sep; 11(1):17990. PubMed ID: 34504210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathophysiological significance of the c.1449T>C/p.(Tyr64Cys) mutation in the CDC42 gene responsible for Takenouchi-Kosaki syndrome.
    Hamada N; Ito H; Shibukawa Y; Morishita R; Iwamoto I; Okamoto N; Nagata KI
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1033-1037. PubMed ID: 32819561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent macrothrombocytopenia in a novel patient with Takenouchi-Kosaki syndrome and review of literature.
    Santoro C; Gaudino G; Torella A; Piluso G; Perrotta S; Miraglia Del Giudice E; ; Nigro V; Grandone A
    Eur J Med Genet; 2021 Dec; 64(12):104358. PubMed ID: 34624555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation.
    Bucciol G; Pillay B; Casas-Martin J; Delafontaine S; Proesmans M; Lorent N; Coolen J; Tousseyn T; Bossuyt X; Ma CS; Schrijvers R; Tangye SG; Moens L; Meyts I
    J Clin Immunol; 2020 May; 40(4):567-570. PubMed ID: 31953712
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Yamano S; Iguchi A; Ishikawa K; Sakamoto A; Uchiyama T; Yanagi K; Kaname T; Kunishima S; Ishiguro A
    Int J Hematol; 2023 Apr; 117(4):622-625. PubMed ID: 36459360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive decline of T and B cell numbers and function in a patient with CDC42 deficiency.
    Kashani P; Marwaha A; Feanny S; Kim VH; Atkinson AR; Leon-Ponte M; Mendoza-Londono R; Grunebaum E
    Immunol Res; 2021 Feb; 69(1):53-58. PubMed ID: 33405195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling Takenouchi-Kosaki syndrome using disease-specific iPSCs.
    Thanasegaran S; Daimon E; Shibukawa Y; Yamazaki N; Okamoto N
    Stem Cell Res; 2023 Dec; 73():103221. PubMed ID: 37918315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopenia.
    Takenouchi T; Okamoto N; Ida S; Uehara T; Kosaki K
    Am J Med Genet A; 2016 Apr; 170A(4):852-5. PubMed ID: 26708094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ending a diagnostic odyssey-The first case of Takenouchi-Kosaki syndrome in an African patient.
    Flynn K; Feben C; Lamola L; Carstens N; Krause A; Lombard Z;
    Clin Case Rep; 2021 Apr; 9(4):2144-2148. PubMed ID: 33936654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delay.
    Takenouchi T; Kosaki R; Niizuma T; Hata K; Kosaki K
    Am J Med Genet A; 2015 Nov; 167A(11):2822-5. PubMed ID: 26386261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel
    Szczawinska-Poplonyk A; Ploski R; Bernatowska E; Pac M
    Front Immunol; 2020; 11():318. PubMed ID: 32231661
    [No Abstract]   [Full Text] [Related]  

  • 15. Expansion of the phenotype of Kosaki overgrowth syndrome.
    Minatogawa M; Takenouchi T; Tsuyusaki Y; Iwasaki F; Uehara T; Kurosawa K; Kosaki K; Curry CJ
    Am J Med Genet A; 2017 Sep; 173(9):2422-2427. PubMed ID: 28639748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes.
    Martinelli S; Krumbach OHF; Pantaleoni F; Coppola S; Amin E; Pannone L; Nouri K; Farina L; Dvorsky R; Lepri F; Buchholzer M; Konopatzki R; Walsh L; Payne K; Pierpont ME; Vergano SS; Langley KG; Larsen D; Farwell KD; Tang S; Mroske C; Gallotta I; Di Schiavi E; Della Monica M; Lugli L; Rossi C; Seri M; Cocchi G; Henderson L; Baskin B; Alders M; Mendoza-Londono R; Dupuis L; Nickerson DA; Chong JX; ; Meeks N; Brown K; Causey T; Cho MT; Demuth S; Digilio MC; Gelb BD; Bamshad MJ; Zenker M; Ahmadian MR; Hennekam RC; Tartaglia M; Mirzaa GM
    Am J Hum Genet; 2018 Feb; 102(2):309-320. PubMed ID: 29394990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Caenorhabditis elegans homolog of FGD1, the human Cdc42 GEF gene responsible for faciogenital dysplasia, is critical for excretory cell morphogenesis.
    Gao J; Estrada L; Cho S; Ellis RE; Gorski JL
    Hum Mol Genet; 2001 Dec; 10(26):3049-62. PubMed ID: 11751687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hemolytic anemia associated with Takenouchi-Kosaki syndrome.
    Ishikawa K; Uchiyama T; Kaname T; Kawai T; Ishiguro A
    Pediatr Int; 2021 Dec; 63(12):1528-1530. PubMed ID: 34403170
    [No Abstract]   [Full Text] [Related]  

  • 19. Qualitative and quantitative characterization of autophagy in Caenorhabditis elegans by electron microscopy.
    Sigmond T; Fehér J; Baksa A; Pásti G; Pálfia Z; Takács-Vellai K; Kovács J; Vellai T; Kovács AL
    Methods Enzymol; 2008; 451():467-91. PubMed ID: 19185736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to Braddock-Carey syndrome phenotype.
    Takenouchi T; Miura K; Uehara T; Mizuno S; Kosaki K
    Am J Med Genet A; 2016 Oct; 170(10):2587-90. PubMed ID: 27256762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.